These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
372 related articles for article (PubMed ID: 9310340)
21. Aldo-keto reductases: Role in cancer development and theranostics. Nagini S; Kallamadi PR; Tanagala KKK; Reddy GB Oncol Res; 2024; 32(8):1287-1308. PubMed ID: 39055885 [TBL] [Abstract][Full Text] [Related]
22. Purification and characterization of two major forms of naloxone reductase from rabbit liver cytosol, new members of aldo-keto reductase superfamily. Yamano S; Ichinose F; Todaka T; Toki S Biol Pharm Bull; 1999 Oct; 22(10):1038-46. PubMed ID: 10549852 [TBL] [Abstract][Full Text] [Related]
23. Crystal structure of CHO reductase, a member of the aldo-keto reductase superfamily. Ye Q; Hyndman D; Li X; Flynn TG; Jia Z Proteins; 2000 Jan; 38(1):41-8. PubMed ID: 10651037 [TBL] [Abstract][Full Text] [Related]
24. The aldo-keto reductase superfamily and its role in drug metabolism and detoxification. Barski OA; Tipparaju SM; Bhatnagar A Drug Metab Rev; 2008; 40(4):553-624. PubMed ID: 18949601 [TBL] [Abstract][Full Text] [Related]
30. Eukaryotic aldehyde dehydrogenase (ALDH) genes: human polymorphisms, and recommended nomenclature based on divergent evolution and chromosomal mapping. Vasiliou V; Bairoch A; Tipton KF; Nebert DW Pharmacogenetics; 1999 Aug; 9(4):421-34. PubMed ID: 10780262 [TBL] [Abstract][Full Text] [Related]
31. cDNA cloning, expression and activity of a second human aflatoxin B1-metabolizing member of the aldo-keto reductase superfamily, AKR7A3. Knight LP; Primiano T; Groopman JD; Kensler TW; Sutter TR Carcinogenesis; 1999 Jul; 20(7):1215-23. PubMed ID: 10383892 [TBL] [Abstract][Full Text] [Related]
32. Molecular cloning, expression, and properties of an unusual aldo-keto reductase family enzyme, pyridoxal 4-dehydrogenase, that catalyzes irreversible oxidation of pyridoxal. Yokochi N; Yoshikane Y; Trongpanich Y; Ohnishi K; Yagi T J Biol Chem; 2004 Sep; 279(36):37377-84. PubMed ID: 15226311 [TBL] [Abstract][Full Text] [Related]
33. Characterization of recombinant YakC of Schizosaccharomyces pombe showing YakC defines a new family of aldo-keto reductases. Morita T; Huruta T; Ashiuchi M; Yagi T J Biochem; 2002 Oct; 132(4):635-41. PubMed ID: 12359080 [TBL] [Abstract][Full Text] [Related]
34. An ethoxyquin-inducible aldehyde reductase from rat liver that metabolizes aflatoxin B1 defines a subfamily of aldo-keto reductases. Ellis EM; Judah DJ; Neal GE; Hayes JD Proc Natl Acad Sci U S A; 1993 Nov; 90(21):10350-4. PubMed ID: 8234296 [TBL] [Abstract][Full Text] [Related]
35. A cluster of eight hydroxysteroid dehydrogenase genes belonging to the aldo-keto reductase supergene family on mouse chromosome 13. Vergnes L; Phan J; Stolz A; Reue K J Lipid Res; 2003 Mar; 44(3):503-11. PubMed ID: 12562828 [TBL] [Abstract][Full Text] [Related]
36. Aldo-keto reductases in which the conserved catalytic histidine is substituted. Di Costanzo L; Penning TM; Christianson DW Chem Biol Interact; 2009 Mar; 178(1-3):127-33. PubMed ID: 19028475 [TBL] [Abstract][Full Text] [Related]
37. Amino acid sequence and characterization of aldo-keto reductase from bakers' yeast. Nakamura K; Kondo S; Kawai Y; Nakajima N; Ohno A Biosci Biotechnol Biochem; 1997 Feb; 61(2):375-7. PubMed ID: 9058981 [TBL] [Abstract][Full Text] [Related]
38. Aldo-keto Reductase 1B15 (AKR1B15): a mitochondrial human aldo-keto reductase with activity toward steroids and 3-keto-acyl-CoA conjugates. Weber S; Salabei JK; Möller G; Kremmer E; Bhatnagar A; Adamski J; Barski OA J Biol Chem; 2015 Mar; 290(10):6531-45. PubMed ID: 25577493 [TBL] [Abstract][Full Text] [Related]
39. Structural and kinetic characterization of a maize aldose reductase. de Sousa SM; Rosselli LK; Kiyota E; da Silva JC; Souza GH; Peroni LA; Stach-Machado DR; Eberlin MN; Souza AP; Koch KE; Arruda P; Torriani IL; Yunes JA Plant Physiol Biochem; 2009 Feb; 47(2):98-104. PubMed ID: 19056286 [TBL] [Abstract][Full Text] [Related]
40. Rabbit 3-hydroxyhexobarbital dehydrogenase is a NADPH-preferring reductase with broad substrate specificity for ketosteroids, prostaglandin D₂, and other endogenous and xenobiotic carbonyl compounds. Endo S; Matsunaga T; Matsumoto A; Arai Y; Ohno S; El-Kabbani O; Tajima K; Bunai Y; Yamano S; Hara A; Kitade Y Biochem Pharmacol; 2013 Nov; 86(9):1366-75. PubMed ID: 23994167 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]